Navigation Links
K-V Pharmaceutical Company Announces Filing of Fiscal 2011 Form 10-K and Schedules Investor Conference Call
Date:6/13/2011

ST. LOUIS, June 13, 2011 /PRNewswire/ -- K-V Pharmaceutical Company (the "Company") (NYSE: KVa/KVb) today announced that it has filed its form 10-K for the fiscal year ended March 31, 2011 with the U.S. Securities and Exchange Commission.

The Company will be holding an investor conference call today at 4:30 p.m. EDT to discuss the Form 10-K as well as provide a general update on other company matters. Participants can listen to the conference call by dialing 866-843-0890 and providing code 2667800. To access the live web cast of the conference call, please go to the investor relations portion of the Company's website under "Conference Calls" at www.kvpharmaceutical.com. Please log-in or dial-in at least 10 minutes prior to the start time to ensure a connection.

A replay of the call will also be available for seven days by calling 877-344-7529 and providing code 445162. An archived version of the webcast will be accessible for 30 days at www.kvpharmaceutical.com.

About K-V Pharmaceutical Company

K-V Pharmaceutical Company is a fully-integrated specialty pharmaceutical company that develops, manufactures, markets, and acquires technology-distinguished branded prescription pharmaceutical products. The Company markets its technology-distinguished products through Ther-Rx Corporation, its branded drug subsidiary.

For further information about K-V Pharmaceutical Company, please visit the Company's corporate Website at www.kvpharmaceutical.com.

Cautionary Note Regarding Forward-looking Statements

This press release contains various forward-looking statements within the meaning of the United States Private Securities Litigation Reform Act of 1995 (the "PSLRA") and that may be based on or include assumptions concerning the operations, future results and prospects of th
'/>"/>

SOURCE K-V Pharmaceutical Company
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Second Quarter 2008 Financial Results on Monday, August 11, at 8:30 A.M. EDT
2. Par Pharmaceutical Reports Second Quarter 2008 Results
3. ISTA Pharmaceuticals Reports Second Quarter 2008 Financial Results
4. SGX Pharmaceuticals Announces Financial Results for the Three and Six Months Ended June 30, 2008
5. ADVENTRX Pharmaceuticals to Report Second Quarter 2008 Results
6. Huifeng Bio-Pharmaceutical (HFGB) Announces USD $1.1 Million Supply Agreement with DNP International Co. Inc.
7. Merrimack Pharmaceuticals Initiates Enrollment in a Phase 1 Study of MM-121, an ErbB3 Antagonist
8. VIA Pharmaceuticals to Present at Fourth Annual Noble Financial Equity Conference
9. Anthera Pharmaceuticals Completes $19 Million Financing; Appoints Christopher S. Henney as Chairman
10. Access Pharmaceuticals to Present at the Noble Financial Equity Conference
11. Indevus Pharmaceuticals Announces Issuance of U.S. Patent for SANCTURA XR(TM)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2015)... -- Working in collaboration with the National Amyloidosis ... , Richmond Pharmacology is the first centre worldwide to ... an investigational RNAi therapeutic being developed for the treatment of ... heart. Read press release ... St Georges University of London , Richmond ...
(Date:3/26/2015)... PRC Clinical, a Silicon-Valley based ... and executive appointments effective immediately. , Mike Catelani will ... member of the Board of Directors. Daniel Head is ... Dowden will assume the position of Senior Director of ... Officer (COO), has been appointed to the position of ...
(Date:3/26/2015)... LANSING, Mich., March 26, 2015 Neogen Corporation ... income for the third quarter of fiscal 2015, which ... to the prior year,s $6,575,000. Earnings per share in ... year ago. Current year-to-date net income increased 17% over ... to $20,621,000, or $0.56 per share, for the same ...
(Date:3/26/2015)... Cranford, NJ (PRWEB) March 26, 2015 ... has partnered with researchers from Yale University’s School of ... provided by study participants during a 4 month-long project. ... impact of providing low income families with free access ... eating habits and diet-related health concerns like high blood ...
Breaking Biology Technology:PRC Clinical Announces Key Management Appointments and Launches East Coast Operations 2PRC Clinical Announces Key Management Appointments and Launches East Coast Operations 3Neogen reports 13% increase in net income 2Neogen reports 13% increase in net income 3Neogen reports 13% increase in net income 4Neogen reports 13% increase in net income 5Neogen reports 13% increase in net income 6Neogen reports 13% increase in net income 7Neogen reports 13% increase in net income 8Yale and New Haven Farms Improving Patient Health with WriteResult's myPROpad™ 2Yale and New Haven Farms Improving Patient Health with WriteResult's myPROpad™ 3
... Cauley Bowman Carney &,Williams, PLLC announces an investigation ... CGPI ). On February 26, 2008,CollaGenex announced ... agreement,with an affiliate of Galderma Pharma S.A. Under ... $16.60 per share in cash for each,share owned. ...
... Pa., Feb. 27 Tengion Inc., a clinical,stage ... and neo-vessels, announced today that it has appointed ... brings more than 25 years,experience as a senior- ... private,companies to Tengion, including expertise in the healthcare, ...
... (Nasdaq: ANSV ) announced today that John P. ... Susquehanna Financial Group,SIGnificant Investment Options in Healthcare Conference in ... EDT., To access the live webcast or the ... to the Investors page, and click on Events.,Please connect ...
Cached Biology Technology:Tengion Appoints Jeff Randall to Board of Directors 2
(Date:3/10/2015)... , March 10, 2015  Continuing its 167-year history ... Hammacher Schlemmer introduces The Eye Scanning Password Authenticator ... granting access to secure websites or sensitive data. ... travelers at international borders, the device has a small ... points of the iris, converting them into an encrypted ...
(Date:3/4/2015)... 2015 Research and Markets ( ... "Global Biometrics Market Forecast and Opportunities, 2020" ... market for biometric authentication systems is projected to ... 2020 The driving forces for this ... government projects and constant development in technology. In ...
(Date:2/25/2015)... , Feb. 25, 2015  ABC Financial Services ... in the Health and Fitness Industry, today announced ... to MYiCLUBonline.  The latest upgrade includes advances to ... of cardless check-in via Identity One fingerprint biometrics. ... time through interactive displays at the International Health, ...
Breaking Biology News(10 mins):Hammacher Schlemmer Introduces The Eye Scanning Password Authenticator 2Global Biometrics Market Forecast and Opportunities, 2020 2Global Biometrics Market Forecast and Opportunities, 2020 3ABC Financial Unveils New Software Enhancements 2ABC Financial Unveils New Software Enhancements 3
... cancer strikes, it often spreads silently into more advanced ... in Nature Nanotechnology , biological engineers and medical ... discovery could provide a much earlier warning signal. ... no proven screening test available for lung cancer," said ...
... Fires have continuously occurred on Earth for at least the last ... has increased at least four-fold, and the total size of burn ... alone. Steadily rising, the U.S.,s bill for fighting wildfires now totals ... the frequency and size of fires are due to human activities? ...
... from the age of the dinosaurs are usually revealed ... team has turned up a treasure trove of Cretaceous ... resilient amber, preserving some 80 million-year-old protofeathers, possibly from ... similar to modern birds, including those that can swim ...
Cached Biology News:MU researchers unveil new method for detecting lung cancer in Nature article 2
... against the complex IV assembly factor SURF1. Cellular ... cells. SURF1 is an important assembly factor for ... in the folding of subunit II and parallel ... particularly ones that result in an absence or ...
Phenytoin-BSA Isolated IgY DFc Drug...
Annexin V Binding Buffer, 10X Concentrate Buffer , 50 ml Consult technical datasheet for details....
...
Biology Products: